Growth in Cuban Biotechnology

The Cuban biotechnology sector has seen growth totalling 162 million Cuban pesos over the past two years, 75 million in 2005 and 87 million in 2006.
One of the leading products is the Hepatitis B vaccine. 170 million doses have been produced to date, and the Cuban product has been used in many WHO campaigns.
The sector produces numerous drugs which not only serve public health in Cuba, but also constitute the country's second largest export area.read more